CannaPharmaRX, Inc.
CPMD
$0.00
$0.00-4.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 627.50K | 138.60K | 656.60K | 231.60K | 335.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 627.50K | 138.60K | 656.60K | 231.60K | 335.30K |
| Cost of Revenue | 1.17M | 673.40K | 1.33M | 852.80K | 837.90K |
| Gross Profit | -540.70K | -534.80K | -674.20K | -621.20K | -502.60K |
| SG&A Expenses | 141.70K | 358.70K | 261.40K | 164.20K | 175.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.31M | 1.03M | 1.59M | 1.02M | 1.01M |
| Operating Income | -682.30K | -893.60K | -935.60K | -785.40K | -677.60K |
| Income Before Tax | -382.00K | -7.55M | -1.48M | -1.41M | -690.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -382.00K | -7.55M | -1.48M | -1.41M | -690.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -382.00K | -7.55M | -1.48M | -1.41M | -690.60K |
| EBIT | -682.30K | -893.60K | -935.60K | -785.40K | -677.60K |
| EBITDA | -682.30K | -- | -- | -785.40K | -677.60K |
| EPS Basic | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 669.79M | 662.50M | 662.50M | 662.50M | 662.50M |
| Average Diluted Shares Outstanding | 669.79M | 662.50M | 662.50M | 662.50M | 662.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |